Source: Virtual Congress 2020 – Precision endotyping of asthma: time for action
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Agache (Brasov (Brasov), Romania). Allergy testing and immunotherapy guidelines. Virtual Congress 2020 – Precision endotyping of asthma: time for action

Member's Comments

No comment yet.

Related content which might interest you: Therapeutic effectpredictors during sublingual immunotherapy for Japanese seasonal allergic rhinitis Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Tolerability and adherence to sublingual immunotherapy with mite vaccines with different schedule in asthmatic children Source: International Congress 2014 – More paediatric asthma Year: 2014 Ultra-rush sublingual immunotherapy: Safety of use for patients with various allergic manifestations Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 The impact of sublingual allergen-specific therapy on asthma control and quality of life Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Clinical effectiveness of anti-IgE therapy in severe asthma with fungus sensitization Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Efficacy of omalizumab in Polish real-world patients Source: International Congress 2016 – Asthma management Year: 2016 The clinical and genetic factors for predicting the response to inhaled corticosteroids Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014 Aspergillus skin hypersensitivity in patients of COPD Source: International Congress 2014 – Clinical allergy Year: 2014 Modern allergy diagnostics in China: The past and present Source: International Congress 2014 – Clinical allergy Year: 2014 Tolerance of ultra-rush immunotherapy in children Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015 Association between control of rhinitis and control of asthma as assessed by validated questionnaires Source: International Congress 2014 – Clinical allergy Year: 2014 Allergy Source: International Congress 2018 – The asthma-allergy “family” Year: 2018 Optimal technique for measuring the IgE blocked by omalizumab Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Lung function response to omalizumab in severe allergic asthma patients in UK clinical practice: APEX II study Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Subcutaneous allergen specific immunotherapy and immunological response in patients with bronchial asthma and allergic rhinitis in India Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Allergen microarray detection of specific IgE in southern Chinese pollen allergy patients Source: International Congress 2014 – Paediatric asthma: epidemiology and risk factors Year: 2014 Allergy symptoms in personnel from a museum complex Source: International Congress 2014 – Clinical allergy Year: 2014 Evaluating omalizumab persistency of response after long-term therapy (XPORT) Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma Source: ERS Webinar 2020: International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma Year: 2020 International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma Source: Eur Respir J 2014; 43: 343-373 Year: 2013